Pharmaceutical and MedTech organizations are continuing to evolve and advance their access-to-medicine approach. In many organizations, there is commitment to expanding patient access and social impact through the corporate strategy, sustainability programmes, greater focus on R&D for low- and middle-income country needs, and broader adoption of practices such as voluntary licensing agreements.

reach52 works with Pharmaceutical and MedTech organizations to translate their social impact goals and access-to-medicine strategies into tangible programmes and impact in low- and middle-income countries. Powered by our unrivalled applications and analytics, we invent and implement sustainable access solutions for medicines and diagnostics that work in these lower-income, remote settings.